Personalis Inc (OQ:PSNL)

Business Focus: Biotechnology & Medical Research

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for PSNL within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET March 30th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Mar 27/20 Mar 27/20 Chen Richard Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -15,000  
Mar 27/20 Mar 27/20 Chen Richard Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 15,000  
Mar 27/20 Mar 25/20 Chen Richard Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -10,000  
Mar 27/20 Mar 25/20 Chen Richard Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 10,000  
Mar 19/20 Mar 17/20 West John Stephen Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 421,000  
Mar 19/20 Mar 17/20 West John Stephen Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 330,000  
Mar 18/20 Mar 16/20 Musil Clinton Direct Ownership Common Stock (right to Buy) A - Grant, award or other under Rule 16b-3(d) 11,000  
Mar 18/20 Mar 16/20 Musil Clinton Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 11,000  
Mar 18/20 Mar 16/20 Chen Richard Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 37,500  
Mar 18/20 Mar 16/20 Chen Richard Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 37,500  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for PSNL within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET March 30th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Mar 27/20 Mar 27/20 Chen Richard Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -15,000  
Mar 27/20 Mar 25/20 Chen Richard Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -10,000  
Mar 27/20 Mar 27/20 Chen Richard Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 15,000  
Mar 27/20 Mar 25/20 Chen Richard Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 10,000  
Mar 19/20 Mar 17/20 West John Stephen Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 421,000  
Mar 19/20 Mar 17/20 West John Stephen Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 330,000  
Mar 18/20 Mar 16/20 Musil Clinton Direct Ownership Common Stock (right to Buy) A - Grant, award or other under Rule 16b-3(d) 11,000  
Mar 18/20 Mar 16/20 Musil Clinton Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 11,000  
Mar 18/20 Mar 16/20 Chen Richard Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 37,500  
Mar 18/20 Mar 16/20 Chen Richard Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 37,500  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $PSNL

Competitors

Competitors with Recent Insider Filings
Iqvia Holdings (N:IQV)
Alnylam Pharmaceuticals (OQ:ALNY)
Vir Biotechnology (OQ:VIR)